Xenikos
Industry · 3 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Terminated | A Study to Compare T-Guard vs Ruxolitinib for Treatment of Steroid-Refractory Acute Graft-vs-Host Disease (BMT Steroid-Refractory Acute Graft Versus Host Disease | Phase 3 | 2022-06-16 |
| Terminated | T-Guard as Treatment for Steroid Refractory Acute GVHD (BMT CTN 1802) Steroid-Refractory Acute Graft Versus Host Disease | Phase 3 | 2019-11-21 |
| Completed | Safety and Efficacy Study of T-Guard to Treat Steroid-resistant Acute GVHD Graft vs Host Disease | Phase 1 / Phase 2 | 2014-03-05 |